ABSTRACT NUMBER: ESOC2026A1595 COMBINED LIPID-LOWERING THERAPY WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH ISHEMIC STROKE AND DYSLIPIDEMIA: A RETROSPECTVE ANALYSIS
Emiliyan Gulev, Stefanela Hodzheva, Dobrinka Kalpachka, Filip Alexiev, Rosen Kalpachki · 2026
Read ABSTRACT NUMBER: ESOC2026A1595 COMBINED LIPID-LOWERING THERAPY WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH ISHEMIC STROKE AND DYSLIPIDEMIA: A RETROSPECTVE ANALYSIS by Emiliyan Gulev, Stefanela Hodzheva, Dobrinka Kalpachka, Filip Alexiev, Rosen Kalpachki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145060.txt.
Description
Emiliyan Gulev and co-authors review a paired cholesterol drug in stroke patients with poor blood fat levels. Their conference abstract from 2026 joins a statin with a second drug that cuts cholesterol uptake from food. The pair hits two paths at once and lowers the harmful fat more than a statin alone.
Records covered 130 patients treated at a large neurology center over one year. Blood fat levels and nerve scores were tracked from the start through follow up. The harmful fat fell by a clear margin on the paired drug. Nerve status also improved over the same span. The pair was well borne, with no major side effects that forced a stop.
Catalog record
| CREATOR | Emiliyan Gulev, Stefanela Hodzheva, Dobrinka Kalpachka, Filip Alexiev, Rosen Kalpachki |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |